02.06.18
Samsung BioLogics has signed a CMO contract with an Asian pharmaceutical company. This contract is in addition to an already existing manufacturing contract. The approximate value of the contract will be $105 million for one year in 2018. The company said other terms of the agreement related to company's name, product, and production factory will not be disclosed.